FDA CIRCULAR 2017-003 – Strict Implementation of the Mandatory Requirement to Secure a LTO CPR or any authorization from FDA Prior to Engaging in the Manufacture Importation Sale Offering for Sale
FDA Circular no. 2017-003 on importers, distributors and manufacturers requiring them to secure an LTO prior of getting an exemption
